Small Molecule Videos

  1. Quick View Of Asymchem's New OEB5 Facility 3/12/2026

    Explore Asymchem’s OEB5 high-potency facility — a 6,000 m², fully enclosed site integrating R&D, manufacturing, and analytics under CPT ≤1 ng/m³ containment.

  2. Quotient Sciences Capabilities Update March 2026: Small Molecule Drug Product 3/11/2026

    This session is designed to help you assess which development approaches, locations, and timelines may be most appropriate for your asset.

  3. Pfizer CentreOne Capabilities Update March 2026: Small Molecule Drug Product 3/11/2026

    From development through commercial supply, our integrated capabilities and rigorous quality standards ensure reliable execution and consistent performance at every stage.

  4. PCI Pharma Services Capabilities Update March 2026: Small Molecule Drug Product 3/11/2026

    Gain insight into our SMART FHD™ approach, designed to accelerate early-phase development through streamlined first-human-dose readiness, as well as its integrated partner network for targeted protein degraders (TPDs).

  5. Mikart Capabilities Update March 2026: Small Molecule Drug Product 3/11/2026

    Discover how integrated formulation development, scalable manufacturing, and robust facility infrastructure can streamline your small molecule programs from early development through commercial production with confidence.

  6. Asymchem Capabilities Update March 2026: Small Molecule Drug Product 3/11/2026

    Guided by a technology-driven approach and supported by a highly coordinated development and manufacturing ecosystem, we provide high-quality, efficient drug product solutions aligned with stringent global regulatory standards.

  7. SK Pharmteco Capabilities Update March 2026: Small Molecule Drug Substance 3/11/2026

    Join Frank Mueller, Executive Director of Business Development, for an overview of our capabilities and global capacity spanning North America, Europe, and Asia.

  8. Novartis Capabilities Update March 2026: Small Molecule Drug Substance 3/11/2026

    Driven by a strong commitment to quality, compliance, and operational excellence, our teams deliver reliable and scalable manufacturing solutions tailored to each partner’s unique requirements.

  9. From Model To Molecule: Combining AI And Experimental Strategies To Transform Drug Development 3/8/2026

    See how integrating AI-driven predictive modeling with well-designed experimental validation can help overcome development challenges, improve decision-making, and support accurate evaluation of API solid-state properties.

  10. Accelerator™ Drug Development 360° CDMO And CRO Solutions 3/4/2026

    Review this coordinated suite of integrated solutions that brings together CDMO and CRO capabilities across clinical research, manufacturing, and clinical supply.